Patient Guide: Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (RXDX-101 Basket Study)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTRXDX-101
Status: NOT_YET_RECRUITING
Condition: NTRK fusion, ROS1 fusion, ALK fusion
Phase: PHASE2

Loading interactive enrollment tools...

The full interactive experience will load momentarily